S. Kasina
About
In The Last Decade
S. Kasina
34 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Radiology, Nuclear Medicine and Imaging 610
- Pulmonary and Respiratory Medicine 357
- Molecular Biology 279
- Oncology 248
- Pediatrics, Perinatology and Child Health 122
Countries citing papers authored by S. Kasina
This map shows the geographic impact of S. Kasina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kasina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kasina more than expected).
Fields of papers citing papers by S. Kasina
This network shows the impact of papers produced by S. Kasina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kasina. The network helps show where S. Kasina may publish in the future.
Co-authorship network of co-authors of S. Kasina
This figure shows the co-authorship network connecting the top 25 collaborators of S. Kasina. A scholar is included among the top collaborators of S. Kasina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Kasina. S. Kasina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 45 | |
| 2 | 127 | |
| 3 | 14 | |
| 4 | 15 | |
| 5 | Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography. | 2 |
| 6 | 3 | |
| 7 | Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent. | 64 |
| 8 | 31 | |
| 9 | Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies. | 65 |
| 10 | 133 | |
| 11 | Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents. | 42 |
| 12 | Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. | 235 |
| 13 | Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers. | 106 |
| 14 | Comparison of a new Tc-99m renal function agent, Tc-99m mercaptoacetyltriglycine, with I-131 OIH | 3 |
| 15 | 1 | |
| 16 | The investigation of radiopharmaceutical components by fast atom bombardment mass spectrometry: the identification of Tc-HIDA and the epimers of Tc-CO2DADS. | 15 |
| 17 | Structure-distribution studies with fluorine-18 labeled pregnenolones: effect of structure on adrenal uptake and elimination | 1 |
| 18 | Design of radiopharmaceuticals for structure distribution studies: some fluorine-18 labeled pregnane derivatives | 3 |
| 19 | 4 | |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.